Financial Results, Upcoming Earnings Schedules, and Prestigious Accolades - Research Report on Rockwood, Sigma-Aldrich, Valspar, Albemarle, and Innophos

Fri Nov 1, 2013 9:01am EDT

* Reuters is not responsible for the content in this press release.

Financial Results, Upcoming Earnings Schedules, and Prestigious Accolades - Research Report on Rockwood, Sigma-Aldrich, Valspar, Albemarle, and Innophos

PR Newswire

NEW YORK, November 1, 2013 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

Today, Analysts' Corner announced new research reports highlighting Rockwood Holdings, Inc. (NYSE: ROC), Sigma-Aldrich Corporation (NASDAQ: SIAL), The Valspar Corporation (NYSE: VAL), Albemarle Corp. (NYSE: ALB), and Innophos Holdings, Inc. (NASDAQ: IPHS). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

Rockwood Holdings, Inc. Research Report

On October 23, 2013, Rockwood Holdings, Inc. (Rockwood) announced that it plans to hold a conference call and a webcast to review the results of operations for Q3 2013 on Wednesday, November 6, 2013 at 10:00 am ET. The Company stated that a live webcast and its replay can be accessed via the Company website. In addition, Rockwood said that the materials used during the call, along with the earnings release and the presentation can be downloaded on the morning of the call from its website. The Full Research Report on Rockwood Holdings, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.AnalystsCorner.com/r/full_research_report/23c3_ROC]

--

Sigma-Aldrich Corporation Research Report

On October 22, 2013, Sigma-Aldrich Corporation (Sigma-Aldrich) reported its financial results for Q3 2013. The Company reported that its sales went up 3.9% YoY to $664 million, and overall organic sales growth was 5% YoY. Diluted EPS for Q3 2013 was $0.98 versus Q3 2012 diluted EPS for $0.92. Sigma-Aldrich stated that its adjusted diluted EPS for the quarter, excluding restructuring charges, was $1.05, compared to Q3 2012 adjusted diluted EPS of $0.94. Sigma-Aldrich President and CEO Rakesh Sachdev commented, "Our overall organic sales growth in the quarter was the best performance in over two years. All of our business units and geographies contributed to growth in the quarter, despite uncertainties in the US federal funding environment. We maintained solid profitability and continued to generate strong free cash flow in the quarter." The Company said that for full-year 2013, it expects adjusted diluted EPS forecast to be in the range of $4.08 to $4.15. The Full Research Report on Sigma-Aldrich Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.AnalystsCorner.com/r/full_research_report/75e5_SIAL]

--

The Valspar Corporation Research Report

On October 29, 2013, The Valspar Corporation (Valspar) reported that it will announce its Q4 FY 2013 and full-year FY 2013 financial results on Tuesday, November 19, 2013, before the markets open. Valspar informed that it will also hold a conference call to review the results on the same day at 11:00 a.m. ET (10:00 a.m. CT). The Company stated that its senior executive management will discuss the results for Q4 FY 2013 and full-year FY 2013, provide an update on the business, and take questions from analysts. In addition, Valspar informed that a webcast of the call can be accessed live via the Investor Relations section of its website. The Full Research Report on The Valspar Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.AnalystsCorner.com/r/full_research_report/fd2d_VAL]

--

Albemarle Corp. Research Report

On October 23, 2013, Albemarle Corp. (Albemarle) reported that it earned a top ten spot on Corporate Responsibility Magazine's "Industry Sector Best Corporate Citizens" list in the Materials category. The Company stated that The "Industry Sector Best Corporate Citizens" list ranks companies by their performance in seven different categories including climate change, employee relations, environment, financial, governance, human rights and philanthropy. Luke Kissam, CEO of Albemarle, commented, "It is certainly an honor to be named to this prestigious list. Albemarle strives to be the most sustainable chemical company in the world, and honors such as this are a testament to the efforts and hard work of our more than 4,000 employees. Each day, they dedicate their time and talents to delivering innovative solutions to our customers and giving back to the communities where we live and operate, and they do so in a way that positions Albemarle to continue to deliver on our commitments to stakeholders." The Full Research Report on Albemarle Corp. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.AnalystsCorner.com/r/full_research_report/ae58_ALB]

--

Innophos Holdings, Inc. Research Report

On October 28, 2013, Innophos Holdings, Inc. (Innophos) announced its financial results for Q3 2013. Net sales for Q3 2013 went up 4.2% YoY to $220 million. Diluted EPS during the quarter was $0.49 versus $0.74 in Q3 2012. Commenting on the results, Randy Gress, CEO of Innophos, said, "We continued to make good progress during the third quarter on our strategic objectives and are pleased that we generated stronger sales volumes amid challenging market conditions. Looking ahead to 2014, we expect continued lower market growth conditions to have an effect on our performance.  However, we are confident that our growth and cost initiatives will enable us to deliver above market growth rates and solid operating margins for our core Specialty Phosphates business.  Taking all of this into consideration, I am pleased to announce that our Board of Directors has approved a 14% increase in our quarterly dividend to $0.40 per share to be paid in the fourth quarter." The Full Research Report on Innophos Holdings, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.AnalystsCorner.com/r/full_research_report/33c5_IPHS]

----

EDITOR NOTES:

  1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
  2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Namrata Maheshwari, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
  3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
  4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
  5. For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
  6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Namrata Maheshwari, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.


AnalystsCorner.com

SOURCE Analysts' Corner

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.